Owl Therapeutics Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- (Cancelled)
- Investors
-
1
Owl Therapeutics General Information
Description
Developer of degenerative artificial intelligence and biomarker-powered therapeutics to enhance and protect microglia to clear brain cell debris. The company specializes in brain health and traumatic brain injury management and leverages artificial intelligence to create a diversified pipeline of small and large-molecule medicines, including therapeutic monoclonal antibodies and fusion proteins, aimed at accelerating the clearance of brain cell debris and limiting inflammation, enabling the healthcare sector to address unmet needs of patients with traumatic brain injury and related conditions.
Contact Information
Website
www.owltherapeutics.comCorporate Office
- 255 Main Street
- Suite 200
- Cambridge, MA 02142
- United States
Corporate Office
- 255 Main Street
- Suite 200
- Cambridge, MA 02142
- United States
Owl Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 10-Jun-2025 | Cancelled | Generating Revenue | |||
| 2. Early Stage VC | Completed | Generating Revenue | ||||
| 1. Spin-Off | 15-May-2023 | Completed | Generating Revenue |
Owl Therapeutics Signals
Owl Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 5 Horizons Capital | Venture Capital | Minority |
Owl Therapeutics FAQs
-
When was Owl Therapeutics founded?
Owl Therapeutics was founded in 2023.
-
Where is Owl Therapeutics headquartered?
Owl Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Owl Therapeutics?
Owl Therapeutics has 5 total employees.
-
What industry is Owl Therapeutics in?
Owl Therapeutics’s primary industry is Drug Discovery.
-
Is Owl Therapeutics a private or public company?
Owl Therapeutics is a Private company.
-
What is Owl Therapeutics’s current revenue?
The current revenue for Owl Therapeutics is .
-
Who are Owl Therapeutics’s investors?
5 Horizons Capital has invested in Owl Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process